Impax Recalls Fenofibrate Capsules Due to Incorrect or Missing Labeling
Impax Laboratories is recalling 42,239 bottles of Fenofibrate Capsules (Micronized) 200 mg because some bottles have incorrect or missing lot and expiration dates.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a labeling error (incorrect or missing lot/expiration dates) rather than a product defect or contamination.
Plain-English summary
Impax Laboratories, Inc. is recalling 42,239 bottles of Fenofibrate Capsules (Micronized) 200 mg, 500-count, Rx Only. The product is distributed by Impax Generics, Hayward, CA, under NDC 0115-0533-02. The recall involves a total of 21,119,500 capsules.
The recall was initiated because some bottles have incorrect or missing lot and/or expiration dates. The affected lots include #10008320, #10008744, #10008974, #10009342, #10010202, #20001416A, #20001557A, #20001675A, and #20001831A, with expiration dates ranging from 05/16 to 06/18. The product was distributed nationwide.
Consumers should check their medication bottles for the NDC 0115-0533-02 and the specific lot numbers listed above. If the lot number matches, consumers should contact their healthcare provider or pharmacist for guidance on whether to continue using the medication or obtain a replacement. The FDA has classified this as a Class III recall, indicating that the labeling error is unlikely to cause adverse health consequences.
The recalled product
- Product
- Fenofibrate Capsules (Micronized) 200 mg, 500-count bottle, Rx Only, Distributed by Impax Generics, Hayward, CA 94544, NDC 0115-0533-02
- Manufacturer
- Impax Laboratories, Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 10008320
- Exp. 05/16 Lot # 10008744
- 10008974
- Exp. 11/16 Lot # 10009342
- Exp. 03/17 Lot # 10010202
- Exp. 09/17 Lot # 20001416A
- Exp. 10/17 Lot # 20001557A
- Exp. 01/18 Lot # 20001675A
- Exp. 03/18 Lot # 20001831A
- Exp. 06/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Impax Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Impax Laboratories, Inc.
See all →- SevereImpax Recalls Lamotrigine Tablets Due to Labeling Mixup
FDA (Drugs) · 2016-12-28
- SevereImpax Recalls Dextroamphetamine Sulfate Tablets Due to Failed Impurity Specifications
FDA (Drugs) · 2016-04-27
- SevereImpax Recalls Dextroamphetamine Sulfate Tablets Due to Failed Impurity Specifications
FDA (Drugs) · 2016-04-27
- LowImpax Recalls Fenofibrate Capsules Due to Incorrect or Missing Labeling
FDA (Drugs) · 2016-04-20
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02